Analyst consensus rating
Gossamer Bio Analyst Rating: Buy
Direct answer
Gossamer Bio's consensus rating is Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $95.40.
Forecast evidence checked October 17, 2026.
Get free Gossamer Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $8.77
- Average price target
- $95.40
- High price target
- $160.00
- Low price target
- $22.40
- Low target gap
- +155.4%
- Target upside
- +987.8%
- High target gap
- +1,724.4%
- Target range width
- 1,569%
- Consensus rating
- Buy
- Analysts
- 6
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Gossamer Bio?
Gossamer Bio has a verified Buy consensus. The same dataset has an average price target of $95.40.
How far are Gossamer Bio's low and high targets from the recorded price?
The low target implies +155.4%, while the high target implies +1,724.4%.
How many analysts are included in Gossamer Bio's consensus?
The verified consensus includes 6 analysts.
How is Gossamer Bio's target upside or downside calculated?
The average target of $95.40 is divided by the recorded price of $8.77, then one is subtracted to produce +987.8%. This does not guarantee a future return.
When was Gossamer Bio's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.